Qualcomm subsidiary Qualcomm Life announced today the development of one-time use biometric patches designed for patient monitoring.
The patch is designed to provide healthcare professionals with real-time patient monitoring data, making the patch applicable for a range of care purposes like perioperative care and assessing the effects of therapeutic interventions. The device can measure a number of biometrics, including clinical thermometry and motion measurements.
“This wearable patch technology will be transformative in its ability to provide timely and accurate data to enable care providers to make better-informed decisions,” Qualcomm Life senior vice president and chief medical officer Dr. James Mault said in a press release. “Utilizing Qualcomm’s 30 years of leadership in inventing new connected ‘things,’ this low-power, cost-effective, single-use design will fuel new, scalable care models as we transition as an industry from episodic, reactive care to more continuous, proactive, intelligent care.”
The company licensed out the design to Benchmark Electronics, which will carry out further development and manufacturing of the product. Benchmark is listed as the device design and manufacturer of record with the FDA and is slated to commercialize the device beginning in 2018. The device is already undergoing clinical validation.
“We are thrilled to work with Qualcomm Life, a global leader in inventing revolutionary connected technologies, to create a new packaged sensor offering for health care companies that is economical, secure and user friendly,” Benchmark CEO Paul Tufano said in the statement. “This collaboration aligns with our mission to deliver high-value solutions and innovative technology for our customers.”
Qualcomm Life developed the patches using its 2net Design platform, a reference design platform for creating electronics to power connected medical devices.
Earlier this year, Qualcomm inked a deal with Johnson & Johnson (NYSE:JNJ) to streamline the healthcare giant’s wireless data capture from its LifeScan’s Onetouch Verio Flex blood glucose meters using the 2net system.
By integrating 2net into Johnson & Johnson’s glucose monitoring system, physicians can access patient data through Bluetooth instead of capturing data manually.